As of November 10, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Strata Critical Medical, Inc. The largest reported stake is Steele ExpCo Holdings, LLC's, at 9%. 15 filings are on record since July 17, 2025 (Schedule 13G/A, August 20, 2026).
Sell to companies like Strata Critical Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Third Point LLC · Sole voting: 0 · Shared voting: 5,126,511 · Sole dispositive: 0 · Shared dispositive: 5,126,511 · SCHEDULE 13D, 2026-10-15
- · Reporting person: Steele ExpCo Holdings, LLC · Sole voting: 7,923,000 · Sole dispositive: 7,923,000 · SCHEDULE 13G/A, 2026-08-20
- · Reporting person: ARK Investment Management LLC · Sole voting: 2,730,855 · Shared voting: 0 · Sole dispositive: 2,730,855 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-08
- · Reporting person: Northern Right Capital Management, L.P. · Sole voting: 0 · Shared voting: 4,398,235 · Sole dispositive: 0 · Shared dispositive: 4,398,235 · SCHEDULE 13G, 2026-06-17
- · Holder: Krstic Velibor · Percent: 0% · SCHEDULE 13D/A
Strata Critical Medical, Inc. has 15 Schedule 13D or 13G filings on record since 2025-07-17. 4 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Steele ExpCo Holdings, LLC | 9% | 7,923,000 | SCHEDULE 13G/A, 2026-08-20 | 2026-06-30 |
| Third Point LLC | 5.8% | 5,126,511 | SCHEDULE 13D, 2026-10-15 | 2026-10-13 |
| BlackRock, Inc. | 5.1% | 4,384,945 | SCHEDULE 13G, 2026-01-21 | 2025-12-31 |
| Northern Right Capital Management, L.P. | 5.1% | 4,398,235 | SCHEDULE 13G, 2026-06-17 | 2026-06-11 |
| ARK Investment Management LLC | 3.16% | 2,730,855 | SCHEDULE 13G/A, 2026-07-08 | 2026-06-30 |
| 0% | 0 | SCHEDULE 13D/A, 2026-05-08 | 2026-05-07 |
Holding shares or following this stake? See who's behind Strata Critical Medical, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Strata Critical Medical, Inc. and the records around it.
Strata Critical Medical, Inc. elsewhere on the record
Companies that share a holder
- Northern Right Capital Management, L.P. also filed stake reports on 2 other companies: Great Elm Group, Inc. (Jul 2026), Great Elm Capital Corp. (May 2026)
- Third Point LLC also filed stake reports on 4 other companies: Third Point Private Capital Income Fund (Nov 2026), Third Point Private Capital Partners (Nov 2026), flyExclusive, Inc. (Jan 2026)
- ARK Investment Management LLC also filed stake reports on 20 other companies: Tempus AI, Inc. (Nov 2026), 10x Genomics, Inc. (Oct 2026), Twist Bioscience Corp (Sep 2026)
Watch Strata Critical Medical, Inc.
Get an email when Strata Critical Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Strata Critical Medical, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Strata Critical Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Strata Critical Medical, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Steele ExpCo Holdings, LLC | 7,923,000 | — | 7,923,000 | — | SCHEDULE 13G/A, 2026-08-20 |
| KSL Capital Partners V GP, LLC | 7,923,000 | — | 7,923,000 | — | SCHEDULE 13G/A, 2026-08-20 |
| Eric Charles Resnick | 7,923,000 | — | 7,923,000 | — | SCHEDULE 13G/A, 2026-08-20 |
| Third Point LLC | 0 | 5,126,511 | 0 | 5,126,511 | SCHEDULE 13D, 2026-10-15 |
| Loeb Daniel S | 0 | 5,126,511 | 0 | 5,126,511 | SCHEDULE 13D, 2026-10-15 |
| Northern Right Capital Management, L.P. | 0 | 4,398,235 | 0 | 4,398,235 | SCHEDULE 13G, 2026-06-17 |
| Northern Right Capital (QP), L.P. | 0 | 1,686,941 | 0 | 1,686,941 | SCHEDULE 13G, 2026-06-17 |
| Northern Right Long Only Master Fund LP | 0 | 1,664,902 | 0 | 1,664,902 | SCHEDULE 13G, 2026-06-17 |
| Northern Right Fund GP LLC | 0 | 1,664,902 | 0 | 1,664,902 | SCHEDULE 13G, 2026-06-17 |
| BC Advisors LLC | 0 | 4,398,235 | 0 | 4,398,235 | SCHEDULE 13G, 2026-06-17 |
| Matthew A. Drapkin | 0 | 4,398,235 | 0 | 4,398,235 | SCHEDULE 13G, 2026-06-17 |
| ARK Investment Management LLC | 2,730,855 | 0 | 2,730,855 | 0 | SCHEDULE 13G/A, 2026-07-08 |
| Catherine D. Wood | 0 | 2,730,855 | 0 | 2,730,855 | SCHEDULE 13G/A, 2026-07-08 |
The latest filing identifies Strata Critical Medical, Inc. by CUSIP 092667104 and gives its principal executive office as 666 Third Avenue, 25th Floor, New York, NY 10017 (SCHEDULE 13D, 2026-10-15).
What the percentages are based on
Item 4(b) of the Schedule 13G is hereby amended and restated as follows: The percentage of shares of Class A Common Stock held by the Reporting Persons is based upon 88,466,806 shares of Class A Common Stock outstanding as of July 28, 2026 as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 4, 2026.Steele ExpCo Holdings, LLC, SCHEDULE 13G/A, 2026-08-20
The following percentage is based on 86,526,570 Common Stock outstanding as of April 27th, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on May 6th, 2026. As of June 17, 2026, the Reporting Persons may be deemed to have beneficially owned approximately 5.1% of the outstanding Common Stock.Northern Right Capital Management, L.P., SCHEDULE 13G, 2026-06-17
Source of funds (Item 3)
The Funds expended an aggregate of $24,452,374 of their own investment capital to acquire the 5,126,511 shares of Common Stock held by them. The Reporting Persons and Funds may effect purchases of shares of Common Stock through margin accounts maintained for them with brokers, which extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable federal margin regulations, stock exchange rules and such firms' credit policies.Third Point LLC, SCHEDULE 13D, 2026-10-15
Purpose of Transaction (Item 4)
Third Point LLC
The Reporting Persons acquired the securities reported herein for investment purposes and believe that the Common Stock is undervalued. The Reporting Persons believe that the underlying business of the Issuer is strong, but not of a scale to support its current overhead and that management incentive options are not aligned with creating shareholder value. Accordingly, the Reporting Persons believe that the Issuer should explore strategic alternatives, including the consideration of a potential sale of the Issuer managed by a reputable investment banking firm. The Reporting Persons may communicate with the Issuer's management and/or Board regarding the foregoing, as well as a broad range of operational, governance and other strategic matters. The Reporting Persons may also communicate with other shareholders or third parties regarding the Issuer, its business, operations and strategic direction, including the potential exploration by the Issuer of strategic alternatives. The Reporting Persons may exchange information with any such persons pursuant to confidentiality or similar agreements. The Reporting Persons may also take steps to explore and prepare for various plans and actions, and propose transactions, before forming an intention to engage in such plans or actions or proceed with such transactions. The Reporting Persons intend to review their investment in the Issuer's shares of Common Stock (or derivatives with respect thereto) on a continuing basis. Depending on …The first part of Item 4 of the SCHEDULE 13D filed 2026-10-15; the filing has the rest
Krstic Velibor
This Amendment No. 3 is being filed to report that the 1,577,500 Warrants previously held by the Reporting Person (SRTAW) expired worthless on May 7, 2026, in accordance with the terms of the Warrant Agreement dated September 12, 2019. As a result of this expiration, the Reporting Person ceased to be the beneficial owner of more than five percent of the class of securities. This filing constitutes the final amendment to the Schedule 13D of the Reporting Person regarding these securities.Item 4 of the SCHEDULE 13D/A filed 2026-05-08
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 5.2% | SCHEDULE 13G |
| 2025-08-11 | Third Point LLC | 6.1% | SCHEDULE 13G |
| 2025-10-17 | BlackRock, Inc. | 4.96% | SCHEDULE 13G/A |
| 2025-11-04 | ARK Investment Management LLC | 7.52% | SCHEDULE 13G/A |
| 2025-11-14 | Third Point LLC | 5.8% | SCHEDULE 13G/A |
| 2026-01-21 | BlackRock, Inc. | 5.1% | SCHEDULE 13G |
| 2026-04-07 | Krstic Velibor | 8.3% | SCHEDULE 13D |
| 2026-04-08 | Krstic Velibor | 12.4% | SCHEDULE 13D/A |
| 2026-04-16 | Krstic Velibor | 16.2% | SCHEDULE 13D/A |
| 2026-04-30 | ARK Investment Management LLC | 8.57% | SCHEDULE 13G/A |
| 2026-05-08 | Krstic Velibor | 0% | SCHEDULE 13D/A |
| 2026-06-17 | Northern Right Capital Management, L.P. | 5.1% | SCHEDULE 13G |
| 2026-07-08 | ARK Investment Management LLC | 3.16% | SCHEDULE 13G/A |
| 2026-08-20 | Steele ExpCo Holdings, LLC | 9% | SCHEDULE 13G/A |
| 2026-10-15 | Third Point LLC | 5.8% | SCHEDULE 13D |
Questions about who owns Strata Critical Medical, Inc.
Who owns Strata Critical Medical, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Strata Critical Medical, Inc.: Steele ExpCo Holdings, LLC (9%, Schedule 13G/A, filed 2026-08-20), Third Point LLC (5.8%, Schedule 13D, filed 2026-10-15), BlackRock, Inc. (5.1%, Schedule 13G, filed 2026-01-21) and Northern Right Capital Management, L.P. (5.1%, Schedule 13G, filed 2026-06-17).
Who are the largest shareholders of Strata Critical Medical, Inc.?
By the share each holder's latest filing reports, the largest holders of Strata Critical Medical, Inc. on this page are Steele ExpCo Holdings, LLC (9%), Third Point LLC (5.8%) and BlackRock, Inc. (5.1%).
When did Steele ExpCo Holdings, LLC buy into Strata Critical Medical, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Steele ExpCo Holdings, LLC on this page is the Schedule 13G/A, filed 2026-08-20, reporting 9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 15 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Strata Critical Medical, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.